Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-T cell development for Cutaneous T cell Lymphoma: current limitations and potential treatment strategies
Van To, Vera J. Evtimov, Graham Jenkin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 17

Showing 17 citing articles:

Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy
Jingjing Ren, Xiaofeng Liao, Julia M. Lewis, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Immune landscape and response to oncolytic virus-based immunotherapy
Chaolong Lin, Wenzhong Teng, Tian Yang, et al.
Frontiers of Medicine (2024) Vol. 18, Iss. 3, pp. 411-429
Closed Access | Times Cited: 5
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL)
Katherine Case, Pamela B. Allen
Current Hematologic Malignancy Reports (2025) Vol. 20, Iss. 1
Closed Access
Unveiling the Role of the Cellular Tumor Microenvironment and the Therapeutic Targets it Provides in Cutaneous T-Cell Lymphoma
Nikolaos A. Chinas, Stella Kaliampou, Vasiliki Nikolaou
Current Oncology Reports (2025)
Open Access
Advances in classification and treatment of primary cutaneous lymphomas
Hong Zheng, Lihua Qiu, Chang Liu, et al.
Annals of Hematology (2025)
Open Access
Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
Ari Pelcovits, Thomas Ollila, Adam J. Olszewski
Cancer Management and Research (2023) Vol. Volume 15, pp. 989-998
Open Access | Times Cited: 7
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Primary Cutaneous CD30-Positive Lymphoproliferative Disorders—Current Therapeutic Approaches with a Focus on Brentuximab Vedotin
Tomasz Stein, Tadeusz Robak, Wojciech Biernat, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 823-823
Open Access | Times Cited: 2
T-cell receptor architecture and clonal tiding provide insight into the transformation trajectory of peripheral T-cell lymphomas
Edith Willscher, Christoph Schultheiß, Lisa Paschold, et al.
Haematologica (2024)
Open Access | Times Cited: 2
Are we there yet? cellular therapies for cutaneous T cell lymphoma
Pınar Ataca Atilla, Erden Atilla
Current Research in Translational Medicine (2023) Vol. 71, Iss. 2, pp. 103390-103390
Closed Access | Times Cited: 4
Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma
Amrita Goyal, Francine M. Foss
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 1-2, pp. 41-58
Closed Access | Times Cited: 1
Immune cells and RBCs derived from human induced pluripotent stem cells: method, progress, prospective challenges
Jinhe Jiang, Rutong Ren, Yan-jie Cheng, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 11
Open Access
The potential role of CD8+ cytotoxic T lymphocytes and one branch connected with tissue-resident memory in non-luminal breast cancer
Ziqi Zhao, Xinyu Ma, Zhengang Cai
PeerJ (2024) Vol. 12, pp. e17667-e17667
Open Access
A Yale Dermatology Perspective on Cutaneous T-Cell Lymphoma: Historical Reflection to Emerging Therapies
Madisen A. Swallow, Richard L. Edelson, Michael Girardi
Clinics in Dermatology (2024)
Closed Access
Harnessing the immune system in the treatment of cutaneous T cell lymphomas
Christopher J. Fay, Katherine C. Awh, Nicole R. LeBoeuf, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 1
Primary Cutaneous CD30 positive Lymphoproliferative Disorders—Current Therapeutic Approach with Focus on Brentuximab Vedotin
Tomas Stein, Tadeusz Robak, Wojciech Biernat, et al.
(2023)
Open Access | Times Cited: 1
Radiation Therapy in Peripheral T-Cell and Cutaneous Lymphomas
Hans Theodor Eich, Khaled Elsayad
Radiation Oncology (2023), pp. 1-17
Open Access
Page 1

Scroll to top